Cargando…
Chemotherapy effect on myocardial fibrosis markers in patients with gynecologic cancer and low cardiovascular risk
BACKGROUND: Patients with gynecologic cancers experience side effects of chemotherapy cardiotoxicity. We aimed to quantify cardiac magnetic resonance (CMR) markers of myocardial fibrosis in patients with gynecologic cancer and low cardiovascular risk who undergo chemotherapy. METHODS: This study is...
Autores principales: | Ye, Lu, Wang, Dan-qing, Yang, Meng-xi, Li, Qing-li, Luo, Hong, Lin, Xiao-juan, Li, Ke-min, Song, Liang, Ma, Yu, Huang, Hui-qiong, Zhong, Lan, Yang, Lu, Zhang, Jian-jun, Gong, Feng-ming, Xu, Hua-yan, Xie, Lin-jun, Yin, Ru-tie, Guo, Ying-kun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10442931/ https://www.ncbi.nlm.nih.gov/pubmed/37614506 http://dx.doi.org/10.3389/fonc.2023.1173838 |
Ejemplares similares
-
Myocardial edema during chemotherapy for gynecologic malignancies: A cardiac magnetic resonance T2 mapping study
por: Yang, Meng-Xi, et al.
Publicado: (2022) -
Histologic validation of myocardial fibrosis measured by T1 mapping: a systematic review and meta-analysis
por: Diao, Kai-yue, et al.
Publicado: (2016) -
Role of noncoding RNAs in liver fibrosis
por: Li, Qing-Yuan, et al.
Publicado: (2023) -
Added value of systemic inflammation markers for monitoring response to neoadjuvant chemotherapy in breast cancer patients
por: Ke, Zi-Rui, et al.
Publicado: (2022) -
Clinical Utility of Strain Imaging in Assessment of Myocardial Fibrosis
por: Gao, Lang, et al.
Publicado: (2023)